We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

88 hedge funds and large institutions have $1.16B invested in Stoke Therapeutics in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 5

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

41% more capital invested

Capital invested by funds: $825M → $1.16B (+$335M)

26% more funds holding

Funds holding: 70 → 88 (+18)

1.8% less ownership

Funds ownership: 105.99% → 104.19% (-1.8%)

43% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 28

Holders
88
Holders Change
+18
Holders Change %
+25.71%
% of All Funds
1.78%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
23
Increased
16
Reduced
28
Closed
5
Calls
$1.48M
Puts
–
Net Calls
+$1.48M
Net Calls Change
+$876K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$33.4M
2
Aviva
Aviva
United Kingdom
+$1.9M
3
RG
Redmile Group
California
+$1.35M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.21M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.12M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$26.7M
2
Millennium Management
Millennium Management
New York
-$6.06M
3
CAM
Cormorant Asset Management
Massachusetts
-$4.67M
4
GGHC
Gilder Gagnon Howe & Co
New York
-$2.27M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.64M -$59.7K -2,090 -4%
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$1.31M +$1.12M +39,244 New
SG Americas Securities
28
SG Americas Securities
New York
$855K +$7.02K +246 +1%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$854K +$22.8K +800 +3%
MAM
30
Martingale Asset Management
Massachusetts
$804K +$685K +24,000 New
TD Asset Management
31
TD Asset Management
Ontario, Canada
$746K – – –
Swiss National Bank
32
Swiss National Bank
Switzerland
$733K – – –
AllianceBernstein
33
AllianceBernstein
Tennessee
$693K -$34.3K -1,200 -5%
BC
34
Birchview Capital
Vermont
$670K – – –
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$653K – – –
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$617K – – –
HS
37
HighVista Strategies
Massachusetts
$572K -$18.6K -652 -4%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$494K -$60.4K -2,115 -13%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$372K – – –
Squarepoint
40
Squarepoint
New York
$363K +$309K +10,837 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$361K +$307K +10,767 New
DekaBank Deutsche Girozentrale
42
DekaBank Deutsche Girozentrale
Germany
$303K +$254K +8,900 New
AC
43
Athanor Capital
New York
$299K -$118K -4,125 -32%
MIM
44
MetLife Investment Management
New Jersey
$262K – – –
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$255K +$218K +7,620 New
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
$247K +$211K +7,381 New
AIG
47
American International Group
New York
$245K -$4.74K -166 -2%
TRCT
48
Tower Research Capital (TRC)
New York
$243K +$72.2K +2,527 +54%
CS
49
Credit Suisse
Switzerland
$243K +$208K +7,281 New
ProShare Advisors
50
ProShare Advisors
Maryland
$230K +$196K +6,857 New
1
2
3 4

STOK Hedge Fund Activity: Q3 2020 in Review

88 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q3 2020, worth a combined $1.16B — up 41% from $825M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new STOK positions and 5 closed out — a net gain of 18 holders — while 16 added to existing stakes and 28 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $33.4M. The largest seller was RA Capital Management, exiting entirely with an estimated $26.7M sold.

  • 88 institutional investors held Stoke Therapeutics (STOK) as of Q3 2020, up from 70 in Q2 2020.
  • Funds reported $1.16B of Stoke Therapeutics stock for Q3 2020, up 41% quarter-over-quarter.
  • 23 funds opened new Stoke Therapeutics positions in Q3 2020 and 5 closed out, a net change of +18 holders.
  • The largest Stoke Therapeutics buyer in Q3 2020 was Fidelity Investments, an estimated $33.4M added.
  • The largest Stoke Therapeutics seller in Q3 2020 was RA Capital Management, an estimated $26.7M sold.

Based on aggregated 13F filings for Q3 2020.